EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

A two‐stage group‐sequential design for delayed treatment responses with the possibility of trial restart

Stephen Schüürhuis iD, Frank Konietschke iD, Cornelia Ursula Kunz iD

Statistics in Medicine · 30.05.2024 · 43 (12) · 2368-2388

DOI: 10.1002/sim.10061 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Statistics in Medicine, online erschienen am 02.04.2024. Verfasst von Stephen Schüürhuis und 2 weiteren Autor:innen. Beteiligte Einrichtung: Charité - Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, Institute of Biometry and Clinical Epidemiology, B…. Hauptthemen laut MEDLINE: Clinical Trials, Phase III as Topic, Research Design. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Deutsche Forschungsgemeinschaft.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Common statistical theory applicable to confirmatory phase III trial designs usually assumes that patients are enrolled simultaneously and there is no time gap between enrollment and outcome observation. However, in practice, patients are enrolled successively and there is a lag between the enrollment of a patient and the measurement of the primary outcome. For single‐stage designs, the difference between theory and practice only impacts on the trial duration but not on the statistical analysis and its interpretation. For designs with interim analyses, however, the number of patients already enrolled into the trial and the number of patients with available outcome measurements differ, which can cause issues regarding the statistical analyses of the data. The main issue is that current methodologies either imply that at the time of the interim analysis there are so‐called pipeline patients whose data are not used to make a statistical decision (like stopping early for efficacy) or the enrollment into the trial needs to be at least paused for interim analysis to avoid pipeline patients. There are methods for delayed responses available that introduced error‐spending stopping boundaries for the enrollment of patients followed by critical values to reject the null hypothesis in case the stopping boundaries have been crossed beforehand. Here, we will discuss other solutions, considering different boundary determination algorithms using conditional power and introducing a design allowing for recruitment restart while keeping the type I error rate controlled.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Clinical Trials, Phase III as TopicResearch DesignHumansModels, StatisticalComputer SimulationTime FactorsData Interpretation, StatisticalTreatment OutcomeTreatment Delay

Stichwörter der Autor:innen

conditional powerdelayed responseerror‐spendinggroup‐sequential designpipeline data

Autor:innen und Institutionen

  • Charité - Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, Institute of Biometry and Clinical Epidemiology, Berlin, Germany.
  • Biostatistics and Data Sciences, Boehringer Ingelheim GmbH & Co. KG, Biberach an der Riß, Germany.

ORCID-Profile: Stephen Schüürhuis, Frank Konietschke, Cornelia Ursula Kunz

Förderung

  • Deutsche Forschungsgemeinschaft

Zitieren

APA

Schüürhuis, S., Konietschke, F., & Kunz, C. U. (2024). A two‐stage group‐sequential design for delayed treatment responses with the possibility of trial restart. Statistics in Medicine, 43(12), 2368-2388. https://doi.org/10.1002/sim.10061

Vancouver

Schüürhuis S, Konietschke F, Kunz CU. A two‐stage group‐sequential design for delayed treatment responses with the possibility of trial restart. Statistics in Medicine. 2024;43(12):2368-2388. doi:10.1002/sim.10061

BibTeX
@article{Schrhuis2024,
  author = {Schüürhuis, Stephen and Konietschke, Frank and Kunz, Cornelia Ursula},
  title = {A two‐stage group‐sequential design for delayed treatment responses with the possibility of trial restart},
  journal = {Statistics in Medicine},
  year = {2024},
  volume = {43},
  number = {12},
  pages = {2368--2388},
  doi = {10.1002/sim.10061}
}
Kostenlos starten →